Novartis’ Spin-off of Sandoz’s Generic and Biosimilar Drugs Business

Bär & Karrer acted as Swiss legal and tax advisor to Novartis and Sandoz. Cravath represented Novartis as U.S. tax counsel.Novartis has completed the spin-off of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here